BIT
CADX

BlackRock Institutional Trust’s CADENCE PHARMACEUTICALS, INC COM STK CADX Stock Holding History

BlackRock Institutional Trust’s Portfolio CADX Stock Details CADX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-6,178
Closed -$86K – 4150
2014
Q1 		$86K Sell
6,178
-1,936,713
-100% -$23.9M ﹤0.01% 3785
2013
Q4 		$17.6M Buy
1,942,891
+78,818
+4% +$569K ﹤0.01% 2045
2013
Q3 		$11.7M Buy
1,864,073
+44,516
+2% +$283K ﹤0.01% 2243
2013
Q2 		$12.4M Buy
+1,819,557
New +$12.7M ﹤0.01% 2169

BlackRock Institutional Trust's CADX Position: Q2 2014 in Review

BlackRock Institutional Trust sold out of CADENCE PHARMACEUTICALS, INC COM STK (CADX) in Q2 2014, closing a stake of 6,178 shares — an estimated $86K sold.

BlackRock Institutional Trust first reported a position in CADX in Q2 2013 and held it in 4 quarters. The position peaked at $17.6M in Q4 2013. 0 funds tracked by Wall St. Rank hold CADX as of Q2 2014.

  • BlackRock Institutional Trust reported no remaining CADENCE PHARMACEUTICALS, INC COM STK position as of Q2 2014 after selling out during the quarter.
  • BlackRock Institutional Trust sold 6,178 CADENCE PHARMACEUTICALS, INC COM STK shares in Q2 2014, an estimated $86K.
  • BlackRock Institutional Trust first reported a position in CADENCE PHARMACEUTICALS, INC COM STK in Q2 2013 and held it in 4 quarters.
  • BlackRock Institutional Trust's CADENCE PHARMACEUTICALS, INC COM STK position peaked at $17.6M in Q4 2013.
  • 0 funds tracked by Wall St. Rank held CADENCE PHARMACEUTICALS, INC COM STK as of Q2 2014.

Based on BlackRock Institutional Trust's 13F filing for Q2 2014, filed 6 Aug 2014.